<DOC>
	<DOCNO>NCT00335153</DOCNO>
	<brief_summary>The primary objective study provide evidence long-term safety tolerability levodopa-carbidopa intestinal gel ( DuodopaÂ® ) 12-months participant advance Parkinson 's disease ( PD ) severe motor fluctuation .</brief_summary>
	<brief_title>Levodopa-Carbidopa Intestinal Gel Open-Label Study Advanced Parkinson 's Disease</brief_title>
	<detailed_description>The study compose screen period follow 3 sequential on-treatment period , follow : - Screening Period ( 28 day ) : determination eligibility discontinuation antiparkinsonian disease medication levodopa-carbidopa immediate release ( LC-oral ) prior nasojejunal ( NJ ) tube placement . - NJ Test Period ( 2 14 day ) : first hospitalization period , Baseline assessment , placement NJ tube , optimization levodopa-carbidopa intestinal gel ( LCIG ) treatment via NJ tube infusion pump ( participant hospitalize NJ tube placement hospitalization require entire duration LCIG treatment optimization ) . - PEG-J Period ( 2 14 day ) : second hospitalization period ; placement PEG-J tube ; optimization LCIG treatment . - Post PEG-J Long-Term Treatment Period ( Day 28 Day 378 ) : LCIG administration via permanent PEG-J tube infusion pump , dosage adjust accord clinical condition .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Carbidopa</mesh_term>
	<mesh_term>Carbidopa , levodopa drug combination</mesh_term>
	<mesh_term>Levodopa</mesh_term>
	<criteria>Idiopathic Parkinson 's disease ( PD ) accord United Kingdom Parkinson 's Disease Society ( UKPDS ) Brain Bank Criteria Levodoparesponsive severe motor fluctuation Recognizable state ( motor fluctuation ) confirm diary Diagnosis unclear suspicion parkinsonian syndrome exist secondary parkinsonism Undergone surgery treatment PD Contraindications levodopa ( narrow angle glaucoma )</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>severe motor fluctuation</keyword>
	<keyword>levodopa</keyword>
	<keyword>levodopa/carbidopa intestinal gel</keyword>
	<keyword>efficacy</keyword>
	<keyword>dyskinesia</keyword>
	<keyword>Parkinson 's Disease</keyword>
	<keyword>carbidopa</keyword>
	<keyword>DUOPA</keyword>
</DOC>